05.14.13
Cook Medical Inc., based in Bloomington, Ind., has released a new 0.35-inch embolization coil, intended for peripheral arterial and venous embolization. Embolizationis a nonsurgical, minimally invasive procedure performed by a physician to block or reduce blood flow in arteries and veins.
The new Retracta coil is designed to provide the physician with more controlled delivery of embolization coils. During this procedure, a physician places a coil that forms within the vessel and causes a clot to form, which may stop or can slow the blood flow. With the Retracta system, the physician reportedly can place the coil and detach it with precision when ready. Visibility of the detachment zone allows a clinician to easily identify when the Retracta is ready to be detached, according to the 50-year-old company. If the physician is not satisfied with the positioning of the coil in the vessel, he or she can fully retract the coil into the catheter and reposition it before detachment.
“When trying to control bleeding, precise coil placement is critical in embolization procedures,” said Andrew Conder, senior global product manager for embolization at Cook Medical. “The Retracta is simple and affordable, and gives physicians control over placement.”
The Retracta coils are based on the construction of Cook Medical’s Nester coils, and use platinum technology to allow soft packing of the coil. According to Cook, physicians can confirm placement accuracy under fluoroscopy by seeing the change in radiopacity at the detachment zone. If the physician wishes, he/she can inject a contrast medium to confirm that the coil is correctly placed. Like the Nester coil, the Retracta can be used out of the package.
The device was cleared by the U.S. Food and Drug Administration in January.
The Retracta coil. Image courtesy of Cook Medical Inc. |
“When trying to control bleeding, precise coil placement is critical in embolization procedures,” said Andrew Conder, senior global product manager for embolization at Cook Medical. “The Retracta is simple and affordable, and gives physicians control over placement.”
The Retracta coils are based on the construction of Cook Medical’s Nester coils, and use platinum technology to allow soft packing of the coil. According to Cook, physicians can confirm placement accuracy under fluoroscopy by seeing the change in radiopacity at the detachment zone. If the physician wishes, he/she can inject a contrast medium to confirm that the coil is correctly placed. Like the Nester coil, the Retracta can be used out of the package.
The device was cleared by the U.S. Food and Drug Administration in January.